Early Lung Cancer Patient Journey in Singapore: Challenges and Recommendations

Early detection of lung cancer is crucial for improving survival rates because it allows for potentially curative treatments; however, most lung cancer cases in Singapore are diagnosed at advanced stages. This review article provides an overview of current practices in the management of early-stage non-small-cell lung cancer (stages I-IIIA) in Singapore (i.e., screening, diagnosis, treatment, and follow-up) while identifying and addressing the associated challenges. Implementing a locally adapted, subsidized national screening program with awareness campaigns can facilitate lung cancer screening uptake. Improving the accessibility and affordability of diagnostic tests and treatments, establishing clear referral pathways and diagnostic workup, adopting multidisciplinary teams, and utilizing cost-effective treatments are critical to timely and effective management of early-stage lung cancers. Establishment of local guidelines for follow-up care, integrating digital technologies and artificial intelligence, and expanding patient assistance programs for follow-up procedures are vital to improving long-term outcomes. Overall, improving the management of early-stage lung cancer necessitates collaboration among healthcare professionals, medical societies, policymakers, patient advocacy groups, and the general public.